Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
DEPDC1
Description:
DEPDC1 is a human protein-coding gene associated with cancer biology and regulation of cellular processes.
Related topics:
Immunotherapy and Immune Responses (10%),
Bladder and Urothelial Cancer Treatments (9%)
Wikidata ID:
wiki/Q18041924
OpenAlex ID:
keywords/depdc1
Identification of Genes Upregulated in ALK -Positive and EGFR/KRAS/ALK -Negative Lung Adenocarcinomas
2011
·
Hirokazu Okayama
, Takashi Kohno
, et al.
·
Cancer Research
·
963
PDF
Identification of early molecular markers for breast cancer
2011
·
Céline Kretschmer
, Anja Sterner-Kock
, et al.
·
Molecular Cancer
·
218
PDF
Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
2015
·
Biljana Stangeland
, Awais A. Mughal
, et al.
·
Oncotarget
·
114
PDF
Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis
2007
·
M Kanehira
, Y Harada
, et al.
·
Oncogene
·
110
Cell-Permeable Peptide DEPDC1-ZNF224 Interferes with Transcriptional Repression and Oncogenicity in Bladder Cancer Cells
2010
·
Yosuke Harada
, Mitsugu Kanehira
, et al.
·
Cancer Research
·
100
DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC
2018
·
Lei Zhang
, Yueyao Du
, et al.
·
Cancer Letters
·
77
Long-term Vaccination with Multiple Peptides Derived from Cancer-Testis Antigens Can Maintain a Specific T-cell Response and Achieve Disease Stability in Advanced Biliary Tract Cancer
2013
·
Atsushi Aruga
, Nobuhiro Takeshita
, et al.
·
Clinical Cancer Research
·
76
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1
2016
·
João Ramalho-Carvalho
, João Barbosa Martins
, et al.
·
Cancer Letters
·
67
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
2016
·
Mutsunori Murahashi
, Yasuki Hijikata
, et al.
·
Clinical Immunology
·
67
Protocadherin 10 inhibits cell proliferation and induces apoptosis via regulation of DEP domain containing 1 in endometrial endometrioid carcinoma
2016
·
Yihua Yang
, Yan Jiang
, et al.
·
Experimental and Molecular Pathology
·
63
DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer
2017
·
Lin Huang
, Keng Chen
, et al.
·
Biochemical and Biophysical Research Communications
·
60
DEPDC1 is a novel cell cycle related gene that regulates mitotic progression
2015
·
Yan Mi
, Chundong Zhang
, et al.
·
BMB Reports
·
60
PDF
Multiple therapeutic peptide vaccines for patients with advanced gastric cancer
2017
·
Yoshiyuki Fujiwara
, Kaoru Okada
, et al.
·
International Journal of Oncology
·
59
PDF
Six Novel Biomarkers for Diagnosis and Prognosis of Esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR
2020
·
liuhai Zheng
, linzhi Li
, et al.
·
Journal of Cancer
·
54
PDF
A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder
2016
·
W. Obara
, M. Eto
, et al.
·
Annals of Oncology
·
52
DEPDC1/LET-99 participates in an evolutionarily conserved pathway for anti-tubulin drug-induced apoptosis
2014
·
Ataman Sendoel
, Simona Maida
, et al.
·
Nature Cell Biology
·
49
Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
2021
·
Lingyu Zhang
, Yu Li
, et al.
·
Scientific Reports
·
47
PDF
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
2015
·
Jacqueline E. Noll
, Kate Vandyke
, et al.
·
Journal of Hematology & Oncology
·
45
PDF
STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis
2020
·
Changmin Liu
, Xiaoming Li
, et al.
·
Aging
·
44
PDF
High Expression of DEPDC1 Promotes Malignant Phenotypes of Breast Cancer Cells and Predicts Poor Prognosis in Patients With Breast Cancer
2019
·
Huishan Zhao
, Mingwei Yu
, et al.
·
Frontiers in Oncology
·
43
PDF
DEPDC1 is required for cell cycle progression and motility in nasopharyngeal carcinoma
2017
·
Xuefei Feng
, Chundong Zhang
, et al.
·
Oncotarget
·
43
PDF
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
2016
·
Suyoun Chung
, Kyoko Kijima
, et al.
·
Oncotarget
·
40
PDF
DEPDC1 as a metabolic target regulates glycolysis in renal cell carcinoma through AKT/mTOR/HIF1α pathway
2024
·
Si-chen Di
, Wen-jin Chen
, et al.
·
Cell Death and Disease
·
38
PDF
In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkers
2021
·
Jongchan Kim
·
World Journal of Surgical Oncology
·
32
PDF
DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway
2019
·
Wubin Guo
, Hui Li
, et al.
·
Oncology Reports
·
32
PDF
Show more works
View as search
Works count:
196
Citation count:
3,599
Year
Topic
Type